Impact of obesity on sepsis mortality: A systematic review

Journal of Critical Care

Volumn 30, Issue 3, 2015, Pages 518-524

  Trivedi, Vrinda ^a   Bavishi, Chirag ^a   Jean, Raymonde ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

BMI; Mortality; Obesity; Sepsis; Systematic review

Indexed keywords

ADIPOCYTOKINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTEREMIA; BODY MASS; CAUSE OF DEATH; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FLUID RESUSCITATION; HUMAN; INFECTION RISK; MORTALITY; NONHUMAN; NURSING CARE; OBESITY; REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; UNDERWEIGHT; COMPLICATION; CRITICAL ILLNESS; FLUID THERAPY; INTENSIVE CARE UNIT; PROCEDURES; PROGNOSIS; SHOCK, SEPTIC; UNITED STATES;

ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; FLUID THERAPY; HUMANS; INTENSIVE CARE UNITS; OBESITY; PROGNOSIS; RESPIRATION, ARTIFICIAL; SEPSIS; SHOCK, SEPTIC; UNITED STATES;

EID: 84928584867     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.12.007     Document Type: Review

References (63)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
2. Murphy S.L., Xu J., Kochanek K.D. Deaths: final data for 2010. Natl Vital Stat Rep 2013, 61(4):1-117.
3. Lagu T., Rothberg M.B., Shieh M.S., Pekow P.S., Steingrub J.S., Lindenauer P.K. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012, 40(3):754-761.
4. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311(8):806-814.
5. Flegal K.M., Kit B.K., Orpana H., Graubard B.I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013, 309(1):71-82.
6. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366(9497):1640-1649.
7. Savva S.C., Lamnisos D., Kafatos A.G. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes 2013, 6:403-419.
8. Oliveros H., Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity 2008, 16(3):515-521.
9. Akinnusi M.E., Pineda L.A., El Solh A.A. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008, 36(1):151-158.
10. Prescott H.C., Chang V.W., O'Brien J.M., Langa K.M., Iwashyna T. Obesity and 1-year outcomes in older Americans with severe sepsis. Crit Care Med 2014, 42(8):1766-1774.
11. Wurzinger B., Dunser M.W., Wohlmuth C., Deutinger M.C., Ulmer H., Torgersen C., et al. The association between body-mass index and patient outcome in septic shock: a retrospective cohort study. Wien Klin Wochenschr 2010, 122(1-2):31-36.
12. Kuperman E.F., Showalter J.W., Lehman E.B., Leib A.E., Kraschnewski J.L. The impact of obesity on sepsis mortality: a retrospective review. BMC Infect Dis 2013, 13(1):377.
13. Wacharasint P., Boyd J.H., Russell J.A., Walley K.R. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care 2013, 17(3):R122.
14. Arabi Y.M., Dara S.I., Tamim H.M., Rishu A.H., Bouchama A., Khedr M.K., et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care 2013, 17(2):R72.
15. Huttunen R., Laine J., Lumio J., Vuento R., Syrjanen J. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect Dis 2007, 7:13.
16. Gaulton T.G., Weiner M.G., Morales K.H., Gaieski D.F., Mehta J., Lautenbach E. The effect of obesity on clinical outcomes in presumed sepsis: a retrospective cohort study. Intern Emerg Med 2014, 9(2):213-221.
17. Cottam D.R., Mattar S.G., Barinas-Mitchell E., Eid G., Kuller L., Kelley D.E., et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004, 14(5):589-600.
18. Vachharajani V., Vital S. Obesity and sepsis. J Intensive Care Med 2006, 21(5):287-295.
19. Vachharajani V., Russell J.M., Scott K.L., Conrad S., Stokes K.Y., Tallam L., et al. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 2005, 12(2):183-194.
20. Singer G., Stokes K.Y., Terao S., Granger D.N. Sepsis-induced intestinal microvascular and inflammatory responses in obese mice. Shock 2009, 31(3):275-279.
21. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83.
22. Venkatesh B., Hickman I., Nisbet J., Cohen J., Prins J. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 2009, 13(4):R105.
23. Vachharajani V., Cunningham C., Yoza B., Carson J., Vachharajani T.J., McCall C. Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity 2012, 20(3):498-504.
24. Teoh H., Quan A., Bang K.W., Wang G., Lovren F., Vu V., et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab 2008, 295(3):E658-E664.
25. Koch A., Sanson E., Voigt S., Helm A., Trautwein C., Tacke F. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011, 26(2):166-174.
26. Walkey A.J., Rice T.W., Konter J., Ouchi N., Shibata R., Walsh K., et al. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med 2010, 38(12):2329-2334.
27. Ahima R.S., Flier J.S. Leptin. Annu Rev Physiol 2000, 62:413-437.
28. Behnes M., Brueckmann M., Lang S., Putensen C., Saur J., Borggrefe M., et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis 2012, 12:217.
29. Bornstein S.R., Licinio J., Tauchnitz R., Engelmann L., Negrao A.B., Gold P., et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998, 83(1):280-283.
30. Yousef A.A., Amr Y.M., Suliman G.A. The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study. Crit Care 2010, 14(2):R33.
31. Dossett L.A., Dageforde L.A., Swenson B.R., Metzger R., Bonatti H., Sawyer R.G., et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect 2009, 10(2):137-142.
32. Hourigan J.S. Impact of obesity on surgical site infection in colon and rectal surgery. Clin Colon Rectal Surg 2011, 24(4):283-290.
33. Yuan K., Chen H.L. Obesity and surgical site infections risk in orthopedics: a meta-analysis. Int J Surg 2013, 11(5):383-388.
34. Bishara J., Farah R., Mograbi J., Khalaila W., Abu-Elheja O., Mahamid M., et al. Obesity as a risk factor for Clostridium difficile infection. Clin Infect Dis 2013, 57(4):489-493.
35. Semins M.J., Shore A.D., Makary M.A., Weiner J., Matlaga B.R. The impact of obesity on urinary tract infection risk. Urology 2012, 79(2):266-269.
36. Wang H.E., Griffin R., Judd S., Shapiro N.I., Safford M.M. Obesity and risk of sepsis: a population-based cohort study. Obesity 2013, 21(12):E762-E769.
37. Littleton S.W. Impact of obesity on respiratory function. Respirology 2012, 17(1):43-49.
38. Fezeu L., Julia C., Henegar A., Bitu J., Hu F.B., Grobbee D.E., et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011, 12(8):653-659.
39. Morgan O.W., Bramley A., Fowlkes A., Freedman D.S., Taylor T.H., Gargiullo P., et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS One 2010, 5(3):e9694.
40. Inoue Y., Koizumi A., Wada Y., Iso H., Watanabe Y., Date C., et al. Risk and protective factors related to mortality from pneumonia among middle-aged and elderly community residents: the JACC study. J Epidemiol 2007, 17(6):194-202.
41. Corrales-Medina V.F., Valayam J., Serpa J.A., Rueda A.M., Musher D.M. The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis 2011, 15(1):e54-e57.
42. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580-637.
43. Longo C., Bartlett G., Macgibbon B., Mayo N., Rosenberg E., Nadeau L., et al. The effect of obesity on antibiotic treatment failure: a historical cohort study. Pharmacoepidemiol Drug Saf 2013, 22(9):970-976.
44. Pai M.P., Bearden D.T. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy 2007, 27(8):1081-1091.
45. Falagas M.E., Karageorgopoulos D.E. Adjustment of dosing of antimicrobial agents for body weight in adults. Lancet 2010, 375(9710):248-251.
46. Blouin R.A., Warren G.W. Pharmacokinetic considerations in obesity. J Pharm Sci 1999, 88(1):1-7.
47. Nawaratne S., Brien J.E., Seeman E., Fabiny R., Zalcberg J., Cosolo W., et al. Relationships among liver and kidney volumes, lean body mass and drug clearance. Br J Clin Pharmacol 1998, 46(5):447-452.
48. Janson B., Thursky K. Dosing of antibiotics in obesity. Curr Opin Infect Dis 2012, 25(6):634-649.
49. Blouin R.A., Bauer L.A., Miller D.D., Record K.E., Griffen W.O. Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother 1982, 21(4):575-580.
50. Hall R.G., Payne K.D., Bain A.M., Rahman A.P., Nguyen S.T., Eaton S.A., et al. Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med 2008, 121(6):515-518.
51. Rich B.S., Keel R., Ho V.P., Turbendian H., Afaneh C.I., Dakin G.F., et al. Cefepime dosing in the morbidly obese patient population. Obes Surg 2012, 22(3):465-471.
52. Ross A.L., Tharp J.L., Hobbs G.R., McKnight R., Cumpston A. Evaluation of extended interval dosing aminoglycosides in the morbidly obese population. Adv Pharm Sci 2013, 2013:194389.
53. Rae L., Pham T.N., Carrougher G., Honari S., Gibran N.S., Arnoldo B.D., et al. Differences in resuscitation in morbidly obese burn patients may contribute to high mortality. J Burn Care Res 2013, 34(5):507-514.
54. Nelson J., Billeter A.T., Seifert B., Neuhaus V., Trentz O., Hofer C.K., et al. Obese trauma patients are at increased risk of early hypovolemic shock: a retrospective cohort analysis of 1,084 severely injured patients. Crit Care 2012, 16(3):R77.
55. McCallister J.W., Adkins E.J., O'Brien J.M. Obesity and acute lung injury. Clin Chest Med 2009, 30(3):495-508. [viii].
56. Bahammam A.S., Al-Jawder S.E. Managing acute respiratory decompensation in the morbidly obese. Respirology 2012, 17(5):759-771.
57. Gong M.N., Bajwa E.K., Thompson B.T., Christiani D.C. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax 2010, 65(1):44-50.
58. O'Brien J.M., Welsh C.H., Fish R.H., Ancukiewicz M., Kramer A.M., National Heart L., et al. Excess body weight is not independently associated with outcome in mechanically ventilated patients with acute lung injury. Ann Intern Med 2004, 140(5):338-345.
59. Morris A.E., Stapleton R.D., Rubenfeld G.D., Hudson L.D., Caldwell E., Steinberg K.P. The association between body mass index and clinical outcomes in acute lung injury. Chest 2007, 131(2):342-348.
60. Hibbert K., Rice M., Malhotra A. Obesity and ARDS. Chest 2012, 142(3):785-790.
61. Muir M., Heese G.A., McLean D., Bodnar S., Rock B.L. Handling of the bariatric patient in critical care: a case study of lessons learned. Crit Care Nurs Clin North Am 2007, 19(2):223-240.
62. Newell M.A., Bard M.R., Goettler C.E., Toschlog E.A., Schenarts P.J., Sagraves S.G., et al. Body mass index and outcomes in critically injured blunt trauma patients: weighing the impact. J Am Coll Surg 2007, 204(5):1056-1061. [discussion 62-4].
63. Olson M., Pohl C. Bedside and radiologic procedures in the critically ill obese patient. Crit Care Clin 2010, 26(4):665-668.